

Blast-off: The Race to IPO in the American Technology Landscape
On May 20, 2026, Space Exploration Technologies Corp. (“SpaceX”) filed an S-1 form with the United States’ Securities and Exchange Commission, indicating its intention to launch an initial public offering (“IPO”). With a total addressable market estimated at US$28.5 trillion, SpaceX aims to capitalize on — among other things — satellite communications (Starlink), space transportation, X’s digital advertising market and the AI-led digital economy. These high-potential revenue
May 281 min read


Humans: 0, Robot: 1 – Sony’s Project Ace Robot Beats the Pros
Developed by Sony AI, a new robot named Ace has outperformed elite table tennis players, marking a significant milestone in AI and robotics. While AI systems have previously rivalled or surpassed human experts in computer-based games, physical sports present a far greater challenge. In particular, table tennis demands split-second reactions, precise motor control and constant adaptation to an opponent’s strategy. These are capabilities that have been traditionally difficult f
May 271 min read


Tim Cook’s Tenure as Apple CEO to End, John Ternus to Succeed Him
Apple recently announced that Tim Cook, the tech giant’s longtime CEO, will step down from the role on September 1, fifteen years after he succeeded late founder Steve Jobs. John Ternus, Apple’s current Senior Vice President of Hardware Engineering will be replacing Cook. The change coincides with a slight shuffle of Apple’s board of directors (the “Board”), taking effect on the same day as Ternus’ appointment to the CEO role. While Cook will remain Apple’s executive chairman
May 72 min read


Gilead Accelerates Immunology Strategy Through Ouro Medicines Acquisition
Gilead Sciences, Inc. (“ Gilead ”), a global biopharmaceutical company, has entered into a definitive agreement to acquire Ouro Medicines (“ Ouro ”), a privately held, clinical-stage biotechnology company. Under the terms of the agreement, Gilead will purchase all outstanding equity of Ouro for US$1.675 billion in cash at closing, with the potential for up to an additional US$500 million in contingent milestone payments. Gilead has been involved in the development of innovat
Mar 301 min read






